Medication info
Megapamo Tablet 20 mg (Famotidine)

Megapamo Tablet 20 mg (Famotidine)

Prescription medicationTabletOral · Intramuscular injection · Intravenous injection
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 1000 tablets/bottle
Approval status
Active

MFDS item code 202000592 · Approved 2020.02.04 · Insurance code 060500340

Summary

Main use
Treatment of gastrointestinal disorders (such as ulcers), preanesthetic medication, and improvement of gastric mucosal lesions and bleeding
Who uses it
Adults
Adult dosage
(Oral) Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults Administer famotidine 20mg orally twice daily (after breakfast and dinner or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injectable formulation, and changed to oral administration once oral administration is possible. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine 10mg orally twice daily (after breakfast and dinner or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve famotidine 20mg in 20ml of normal saline or glucose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Change to oral administration once oral administration is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20ml of normal saline or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (such as ulcers), preanesthetic medication, and improvement of gastric mucosal lesions and bleeding

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
View approved original text

This medication is primarily used for the treatment of gastric and duodenal ulcers, anastomotic ulcers, and upper gastrointestinal bleeding due to peptic ulcers and acute stress ulcers. It is also effective for bleeding caused by hemorrhagic gastritis and gastroesophageal reflux disease, and provides assistance in conditions of excessive gastric acid secretion such as Zollinger-Ellison syndrome. It is used to alleviate symptoms such as erosion, bleeding, redness, and edema of the gastric mucosa during acute exacerbations of acute or chronic gastritis. The injectable form is mainly used for the treatment of upper gastrointestinal bleeding, Zollinger-Ellison syndrome, and pre-anesthetic medication. This medication significantly contributes to alleviating symptoms of gastrointestinal diseases and maintaining the health of the gastric mucosa.

Dosage and Administration

Adult dosage

(Oral) Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults Administer famotidine 20mg orally twice daily (after breakfast and dinner or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injectable formulation, and changed to oral administration once oral administration is possible. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine 10mg orally twice daily (after breakfast and dinner or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve famotidine 20mg in 20ml of normal saline or glucose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week. Change to oral administration once oral administration is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20ml of normal saline or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients with allergies to specific components or inherited lactose intolerance. It should be used with caution in patients with poor kidney or liver function, heart disease, a history of drug allergies, and in elderly patients. While rare, serious allergic reactions, blood abnormalities, severe skin disorders, liver dysfunction, muscle damage, cardiac arrhythmias, neurological issues, renal deterioration, and pulmonary diseases may occur during treatment, so any unusual symptoms should be promptly discussed with a physician. This medication dissolves in the mouth but is not absorbed in the mouth, so it should be swallowed with water or saliva. Regular blood tests and tests for liver and kidney function are recommended. Care should be taken due to possible interactions with other drugs, especially when taking specific antifungals or anticancer medications. Pregnant or breastfeeding women should carefully consider the risks and benefits before using this medication, and in the case of breastfeeding, discontinuation of breastfeeding is advisable. The safety for children has not been fully established, so caution is needed in its use. In particular, this medication can mask symptoms of gastric cancer, so it should only be used after confirming that it is not cancer. When taking this medication, it is advisable to use the minimum effective dose based on symptoms, and if there is no effect, to switch to another treatment. Elderly patients may have prolonged drug retention due to decreased renal function, necessitating a reduction in dosage or an increase in dosing interval.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • respiratory distress
  • generalized pruritus
  • angioedema
  • face swelling
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 79 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous eosinophilic syndrome
  • Riley's syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • serum muscle enzyme elevation
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized convulsions
  • tonic convulsions
  • clonic convulsions
  • interstitial nephritis
  • acute renal failure
  • fever
  • rash
  • urticaria
  • erythema
  • face swelling
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • heart block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • heaviness
  • reversible confusional state
  • depression
  • convulsions
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle spasms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is important to keep the storage temperature between 1 to 30 degrees Celsius at room temperature. This will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.